About Manifold Bio
Manifold Bio is a Healthcare company based in United States founded in 2018 by Gleb Kuznetsov, Shane Lofgren, Pierce Ogden, and George M Church. Research lab engaged in pharmacological measurements on therapeutic protein variants. Manifold Bio has raised $78.19 million across 3 funding rounds from investors including Tencent, Triatomic Capital and Future Perfect Ventures. The company has 22 employees. Its chief executive, as recorded, is Gleb Kuznetsov. Manifold Bio offers products and services including Tissue-Targeted Biologics and mCodes Technology. Its focus areas include Medical Research Labs. Its legal entity is Manifold Bio, Inc.
Company details
Manifold Bio was founded in 2018 and is based in the United States. Operations focus on the biotechnology sector, where pharmacological assessments of therapeutic protein variants are performed. The lab supports drug development through precise measurements and analysis. Key leadership includes co-founders Gleb Kuznetsov as CEO, Shane Lofgren, Pierce Ogden as CSO, and George M. Church. Research activities are centered on advancing protein-based therapeutics.
- Headquarters United States
- Employees 22
- Founders Gleb Kuznetsov, Shane Lofgren, Pierce Ogden, George M Church
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website manifold.bio
- Social LinkedIn
- Legal Name Manifold Bio, Inc
- Total Equity Funding$78.19M (USD)
in 3 rounds
- Latest Funding Round$32.78M (USD), Series A
Nov 2024
- InvestorsTencent
& 8 more
- Employee Count22
Products & Services of Manifold Bio
Manifold Bio offers a comprehensive portfolio of products and services, including Tissue-Targeted Biologics and mCodes Technology.
Targeted biologics are developed using high-throughput in vivo screening and AI to optimize pharmacokinetics and biodistribution for tissue-specific delivery
mCodes technology is utilized as multiplexed protein barcodes for tracking and measuring biologics across tissues with high sensitivity
Funding Insights of Manifold Bio
Manifold Bio has successfully raised a total of $78.19M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $32.78 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $78.19M
- Total Rounds 3
- Last Round Series A — $32.78M
- First Round $5.4M
(Aug 2020)
- Investors Count 9
All 3 funding rounds of Manifold Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $32.78M | Series A | – | – | – |
| Jun 2022 | $40M | Series A | – | Triatomic | |
| Aug 2020 | $5.4M | Seed | – | Playground Global |
9 investors in total: 9 institutional.
Investors in Manifold Bio
Manifold Bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Triatomic Capital and Future Perfect Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Triatomic Capital is focused on investing in century-defining technological themes. | triatomic.ai | Palo Alto, United States | ||
Venture capital firm focused on blockchain technology sectors | futureperfectventures.com | New York, United States | ||
Horizons Ventures is focused on investing in deep science and technology. | horizonsventures.com | Hong Kong, China | ||
Venture capital firm focused on multiple sectors | fiftyyears.com | San Francisco, United States | ||
Tech startups are funded by S32, a venture capital entity. | s32.com | Sunnyvale, United States | ||
Venture capital fund focused on tech startups | playground.global | Palo Alto, United States | ||
Venture capital and private equity are provided by GETTYLAB to technical founders. | 2014 | gettylab.com | San Francisco, USA | |
Value-added internet, mobile, and telecom services are provided in China. | 1998 | tencent.com | Shenzhen, China | |
| fast.xyz |
Investor details for Manifold Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Manifold Bio
35 people are tracked at Manifold Bio (10 in leadership, 5 in board & advisors, 20 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Gleb Kuznetsov | Co-Founder & CEO | Leadership |
Shane Lofgren | Co-Founder | Leadership |
Pierce Ogden | Co-Founder & CSO | Leadership |
George M Church | Co-Founder | Leadership |
Alvaro García | Associate Director & Head, In Vivo | Leadership |
Kate Nudel | Associate Director & Head, Applied Biology | Leadership |
Tianxiao Sun | Director, Head Of Lab Automation | Leadership |
Kimberly Scearce-Levie | Chief Scientific Officer | Leadership |
Naveen Mehta | Senior Director, Drug Discovery And Early Development | Leadership |
Sean Carroll | Director, Portfolio & Business Development | Leadership |
Ryan P. Adams | Advisor | Board & advisors |
Eliezer Van Allen | Advisor | Board & advisors |
Alex Lugovskoy | Scientific Advisor | Board & advisors |
George Church | Co-Founder | Board & advisors |
Dennis Benjamin | Scientific Advisor | Board & advisors |
Isabel Albuja | Research Associate | Team |
Alex Reis | Principal Scientist | Team |
Alex Gerew | Senior Associate Scientist | Team |
Margaret Prescott | Associate Scientist | Team |
Brianna Unda | Scientist II | Team |
15 more people are available in the full profile.
Complete people profiles for Manifold Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Manifold Bio
3 dated milestones of Manifold Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Manifold Bio is founded.
- Funding First funding round of $5.4M.
- Funding Latest funding round, Series A, of $32.8M.
Web traffic of Manifold Bio
The website of Manifold Bio (manifold.bio) receives about 6.6K visits a month and ranks #4,045,844 among all websites worldwide, #5,076 in Biotechnology and Pharmaceuticals.
- Monthly visits6.6K
▲ 44.3% vs previous month
- Unique visitors1.9K
per month
- Global rank#4,045,844
among all websites
- Category rank#5,076
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit1.7
- Average visit34 sec
- DevicesDesktop 49% · Mobile 51%
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as Manifold Bio (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 | ||
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Manifold Bio
Manifold Bio was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Manifold Bio is headquartered in United States.
Gleb Kuznetsov is the CEO of Manifold Bio, as recorded in our data. They have also founded this company.
Manifold Bio is a funded company, having raised a total of $78.19M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.4M, raised on Aug 2020.
Manifold Bio has 22 employees.
Manifold Bio was founded in 2018 and is based in the United States. Operations focus on the biotechnology sector, where pharmacological assessments of therapeutic protein variants are performed. The lab supports drug development through precise measurements and analysis. Key leadership includes co-founders Gleb Kuznetsov as CEO, Shane Lofgren, Pierce Ogden as CSO, and George M. Church. Research activities are centered on advancing protein-based therapeutics.
Manifold Bio offers Tissue-Targeted Biologics and mCodes Technology.
Manifold Bio has 9 investors. Key investors include Tencent, Triatomic Capital, Future Perfect Ventures, Horizons Ventures, and Fifty Years.
Manifold Bio operates through Manifold Bio, Inc.